文献速递复苏、休克与脓毒症儿科与产科急症

儿童院外心脏骤停发生于急救人员到达前后:一项回顾性研究

Paediatric out-of-hospital cardiac arrest occurring before and after emergency medical service arrival: a retrospective study.
PubMed 文献 · Resuscitation · 2026-08-15
一句话结论儿童EMS目击的院外心脏骤停较旁观者目击者出院生存和院前ROSC的调整比值比显著更高,但该研究为回顾性观察,不能证明因果。

在EMS治疗的病例中,59.8%无人目击、32.0%为旁观者目击、8.1%为EMS目击。多因素logistic回归校正年龄、性别、骤停地点、地区、病因、初始心律和年份后,EMS目击者较旁观者目击者出院生存的调整比值比(AOR)为1.91(95%CI 1.04-3.52),院前ROSC的AOR为1.83(95%CI 1.20-2.77),无人目击者所有结局均更差。研究提示早期专业干预可能改善预后,但设计为回顾性观察,需前瞻性验证。

要点

  • 在EMS治疗的儿童OHCA中,EMS目击者出院生存AOR 1.91(95%CI 1.04-3.52),院前ROSC AOR 1.83(95%CI 1.20-2.77),均优于旁观者目击者。
  • 无人目击的儿童OHCA占EMS治疗病例的59.8%,其所有结局均显著更差,是预后最差亚组。
  • EMS目击的儿童OHCA仅占EMS治疗病例的8.1%,其发生率在25年间保持稳定,而无人目击和旁观者目击发生率均下降(p<0.001)。
  • 该研究为回顾性注册登记分析,校正了年龄、性别、骤停地点、地区、病因、初始心律和年份,但不能排除残余混杂,不能确立因果。
  • 结论支持儿童特异性策略以改善对这类事件的识别和响应,但原文未给出具体策略内容或推荐等级。

适用人群与场景

  • 分析对象为其中接受了复苏尝试的1891例(71.5%)EMS治疗病例。
  • 原文未提及排除标准、院前或院内场景的进一步分层,也未提及具体纳入标准细节。

诊断标准与关键阈值

  • 目击状态分为三类:无人目击、旁观者目击、EMS目击。
  • 原文未提及儿童OHCA的诊断标准、复苏启动或停止的具体阈值或评分界值。

处置流程与药物剂量

  • 原文未提及具体的复苏处置流程、药物剂量、给药途径、频次或目标值。
  • 原文仅指出EMS目击的儿童OHCA与更高的出院生存和院前ROSC调整比值比相关,并支持需要儿童特异性策略改善识别和响应,但未给出具体策略条款。

红旗征与不能漏的情况

  • 无人目击的儿童OHCA占EMS治疗病例的59.8%,其所有结局均显著更差,属于预后最差亚组。
  • 原文未提及需要立刻处理或不能漏诊的具体红旗征及其处理措施。

研究设计与关键结果

  • 样本量:共2645例儿童OHCA由EMS接诊,其中1891例(71.5%)接受复苏尝试;EMS治疗病例中59.8%无人目击、32.0%旁观者目击、8.1%EMS目击。
  • 主要终点:校正年龄、性别、骤停地点、地区、病因、初始心律和年份后,EMS目击者较旁观者目击者出院生存AOR 1.91(95%CI 1.04-3.52),院前ROSC AOR 1.83(95%CI 1.20-2.77)。
  • 关键次要终点:无人目击的OHCA在所有结局上均显著更差;无人目击和旁观者目击的OHCA发生率在25年间下降(p<0.001),EMS目击发生率保持稳定。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(注册库分析)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:回顾性设计、单注册库数据、观察性研究不能确立因果、可能存在残余混杂;原文未提及其他局限。

对床旁实践的改变

  • 该研究提示EMS目击的儿童OHCA较旁观者目击者出院生存和院前ROSC的调整比值比更高,支持早期专业干预的重要性,但为回顾性观察,不能据此改变具体复苏流程或药物方案。
  • 无人目击的儿童OHCA占多数且结局最差,提示对该亚组需关注识别和响应,但原文未给出具体改进措施。
  • 适用人群为18岁以下EMS接诊的OHCA病例;原文未提及不适用人群。
  • 常见陷阱:将回顾性观察的调整比值比误读为因果效应或决策阈值;原文未给出任何可操作的阈值或推荐等级。

指南或共识出处

  • 原文未提及指南或共识名称;研究数据来自维多利亚州救护车心脏骤停登记库(VACAR)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

AIM: To examine the association between witness status and the incidence, characteristics, and survival outcomes of paediatric out-of-hospital cardiac arrest (OHCA) attended by emergency medical services (EMS).

METHODS: We conducted a retrospective cohort study of paediatric (<18 years) OHCA cases attended by EMS between 1 January 2000 and 31 December 2024. Cases were identified from the Victorian Ambulance Cardiac Arrest Registry (VACAR). Witness status was categorised as unwitnessed, bystander witnessed, or EMS witnessed. Multivariable logistic regression was used to evaluate the association between witness status and outcomes, adjusting for age, sex, arrest location, region, aetiology, initial rhythm and year.

RESULTS: A total of 2645 paediatric OHCAs were attended by EMS, of which 1891 (71.5%) received a resuscitation attempt. Among EMS-treated cases, 59.8% were unwitnessed, 32.0% were bystander witnessed, and 8.1% were EMS witnessed. The incidence of unwitnessed and bystander witnessed OHCA declined over the 25-year period (p < 0.001), whereas EMS witnessed incidence remained stable. After adjustment, EMS witnessed arrests were associated with significantly higher odds of survival to hospital discharge (AOR 1.91, 95% CI 1.04-3.52) and prehospital ROSC (AOR 1.83, 95% CI 1.20-2.77) compared with bystander witnessed arrests, while unwitnessed arrests had substantially lower survival across all outcomes.

CONCLUSION: Paediatric OHCA witnessed by EMS is associated with significantly higher adjusted odds of survival compared with bystander witnessed events. These findings highlight the importance of early professional intervention and support the need for paediatric-specific strategies to improve recognition and response to these events.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Kennedy C, Nehme E, McManamny T, et al. Paediatric out-of-hospital cardiac arrest occurring before and after emergency medical service arrival: a retrospective study. Resuscitation. 2026. PMID: 42603602. doi:10.1016/j.resuscitation.2026.111267

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。